hirudin

Hirudin is a potent, direct thrombin inhibitor originally derived from the salivary glands of the medicinal leech Hirudo medicinalis. Our recombinant hirudin is produced in Saccharomyces cerevisiae and purified to ≥98% by HPLC, appearing as a white to off-white lyophilized powder. It is supplied with comprehensive documentation, making it suitable for pharmaceutical R&D and clinical-grade applications.

Synonimy: Hirudin (recombinant), r-hirudin, desulfato-hirudin, Hirudin variant-1, Hirudin HV1, leech-derived thrombin inhibitor

Zastosowania

• Anticoagulant therapy research, particularly for heparin-induced thrombocytopenia (HIT)
• Thrombin inhibition studies in coagulation cascade assays
• Development of diagnostic reagents and medical devices
• Custom peptide and protein modification projects

Jakość i dokumentacja

Each batch is tested for assay (HPLC ≥98%), biological activity (antithrombin units), loss on drying (≤5.0%) and heavy metals (≤10 ppm). Full COA, MSDS and TDS are provided per batch; stability data available on request.

Opakowania i zaopatrzenie

Standard packaging: 10 mg, 50 mg, 100 mg; custom packing available. In-stock items ship within 3-5 days; MOQ from 10 mg. For pricing, samples and bulk orders, contact our sales team.

Zapytanie ofertowe

• Nasz adres: 280 Main Street, Xi’an, Shaanxi, Chiny
• LyvBio Sp. z o.o. — E-mail: info@lyvbio.com